Persistence Market Research

Liquid Biopsy Products Market Expected to Witness a Sustainable Growth over 2016 - 2024 - Persistence Market Research

The Liquid Biopsy Products Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.


New York, NY -- (SBWIRE) -- 03/08/2017 -- Liquid Biopsy Products Market: Key Players

Some players operating in liquid biopsy products market are Biocept Inc., Myriad Genetics, Qiagen, Roche, Bio-Rad Laboratories Inc., Trovagene Inc., Guardant Health, Inc., Janssen Diagnostics, LLC, Fraunhofer – Gesellschaft, and MDxHealth S.A., Genomic Health to name a few.

Liquid Biopsy Products Market: Regional Overview

The global market for liquid biopsy product is segmented on basis of disease type, products & services, circulating biomarkers, end user and geography. The Liquid Biopsy Market, based on disease type (Type of Cancer) segmentation has been categorized into Lung Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Prostate Cancer and Other Cancers (Melanoma, Bladder Cancer and Ovarian Cancer). On the basis of Products and Services, the global market has been segmented into Instruments, Reagents, Services and Software. By Circulating Biomarkers segmentation the global market has the segments of Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Extracellular vesicles (EVs) and Other Biomarkers (Circulating RNA and Protein). The end users of liquid biopsy products are Hospital & Physician Laboratories, Academic & Research Centers, Reference Laboratories and Others End User (Public Health Laboratories, Pathology Laboratories, And Small Molecular Laboratories).

In 2016, largest share of the global market is expected to be accounted by North America due to factors such as easy accessibility and high adoption of advanced diagnostic technologies. The technologies like PCR and NGS play an important role. Also, among healthcare professionals, increasing prevalence of cancer in the U.S. and Canada and continuous technological advancements in liquid biopsy is remarkable. Asia-Pacific liquid biopsy products market is however estimated to witness the highest growth during the forecast period owing to the increasing focus of market players on this region.

Browse Full Report summary and to request sample report and table of content@